Plante Moran Financial Advisors’s abrdn Life Sciences Investors HQL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-2,181
Closed -$43.9K 1046
2021
Q3
$45K Hold
2,181
0.01% 403
2021
Q2
$47K Hold
2,181
0.01% 385
2021
Q1
$43K Buy
+2,181
New +$44.9K 0.01% 392
2020
Q1
Sell
-50
Closed -$1K 778
2019
Q4
$1K Sell
50
-750
-94% -$12.3K ﹤0.01% 720
2019
Q3
$12K Hold
800
﹤0.01% 561
2019
Q2
$13K Hold
800
﹤0.01% 532
2019
Q1
$14K Hold
800
﹤0.01% 517
2018
Q4
$12K Buy
+800
New +$14.1K ﹤0.01% 480
2018
Q2
Sell
-1,670
Closed -$32K 891
2018
Q1
$32K Hold
1,670
0.02% 427
2017
Q4
$33K Hold
1,670
0.02% 421
2017
Q3
$36K Buy
+1,670
New +$35.5K 0.02% 373

Other funds holding HQL

Plante Moran Financial Advisors's HQL Position: Q4 2021 in Review

Plante Moran Financial Advisors sold out of abrdn Life Sciences Investors (HQL) in Q4 2021, closing a stake of 2,181 shares — an estimated $43.9K sold.

Plante Moran Financial Advisors first reported a position in HQL in Q3 2017 and held it in 11 quarters. The position peaked at $47K in Q2 2021. 67 funds tracked by Wall St. Rank hold HQL as of Q4 2021.

  • Plante Moran Financial Advisors reported no remaining abrdn Life Sciences Investors position as of Q4 2021 after selling out during the quarter.
  • Plante Moran Financial Advisors sold 2,181 abrdn Life Sciences Investors shares in Q4 2021, an estimated $43.9K.
  • Plante Moran Financial Advisors first reported a position in abrdn Life Sciences Investors in Q3 2017 and held it in 11 quarters.
  • Plante Moran Financial Advisors's abrdn Life Sciences Investors position peaked at $47K in Q2 2021.
  • 67 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q4 2021.

Based on Plante Moran Financial Advisors's 13F filing for Q4 2021, filed 9 Feb 2022.